Can treatment with Teriflunomide cure it?

Teriflunomide (Teriflunomide) is an approved first-line disease-modifying drug for relapsing multiple sclerosis (RMS). It works by blocking the de novo synthesis of pyrimidines, thereby exerting a cytostatic effect on proliferating B cells and T cells. Research results show that teriflunomide promotes oligodendrocyte homeostasis and myelination in vitro.

Multiple SclerosisThe adult central nervous system (CNS) of patients with multiple sclerosis (MS) exhibits only limited regenerative capacity and impaired repair processes, resulting in neurological disability and long-term reduced quality of life. Although relapsing MS (RMS) can be treated with a number of established immunomodulatory drugs, the disease itself remains incurable and develops into progressive stages (PMS) with irreversible functional defects. Teriflunomide may help control the symptoms of multiple sclerosis, but it does not cure it. Continue taking teriflunomide even if you feel well. Do not stop taking teriflunomide without your doctor's guidance.

The original drug Teriflunomide has been marketed in China and has entered the scope of medical insurance through medical insurance reimbursement standards. It may be limited to patients with multiple sclerosis who are ineffective in conventional treatments. However, the reimbursement ratio is different in different regions, and the price after reimbursement is different. SpecificationsThe price of 14mg*28 tablets per box is about 10,000 yuan. For families with heavy financial burdens, the high price may increase their pressure. Cheaper generic drugs are also sold in other overseas countries. The pharmaceutical ingredients of generic drugs are basically the same as those of the original drugs. The price of 14mg*30 tablets produced by an Indian pharmaceutical factory is around RMB 800 per box (the price may fluctuate due to the exchange rate).